Serum transforming growth factor-β1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease

Transplantation

Volumn 67, Issue 1, 1999, Pages 59-65

  Liem, Linda M ^a   Fibbe, Wim E ^a   Van Houwelingen, Hans C ^a   Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

EID: 0033556556     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00009     Document Type: Article

References (34)

1. Beatty PG, Hansen JA, Lonton GM, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443.
2. Chao NJ, Schlegel PG. Prevention and treatment of graft-versus-host disease. Ann N Y Acad Sci 1995; 770: 130.
3. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
4. Derynck R. Transforming growth factor-beta. In: Thomson AW, ed. The cytokine handbook. San Diego: Academic Press, 1994: 319.
5. Flaumenhaft R, Kojima S, Abe M, Rifkin DB. Activation of latent transforming growth factor β. Adv Pharmacol 1993; 24: 51.
6. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets: identification of a major storage site, purification and characterization. J Biol Chem 1983; 258: 7155.
7. Roberts AB, Joyce ME, Bolander ME, Sporn MB. Transforming growth factor-beta (TGF-β): a multifunctional effector in both soft and hard tissue regeneration. Growth Factors in Health and Disease 1990; 4: 89.
8. Kim S, Romeo D, Yoo YD, Park K. Transforming growth factor-β: expression in normal and pathological conditions. Horm Res 1994; 42: 5.
9. Ruscetti F, Varesio L, Ochoa A, Ortaldo J. Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann N Y Acad Sci 1993; 685: 488.
10. Maeda H, Shiraishi A. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol 1996; 156: 73.
11. + T cells. J Immunol 1995; 155: 609.
12. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286.
13. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1.
14. Hoyt DG, Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 1988; 246: 765.
15. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170: 727.
16. Phan SH, Gharaee-Kermani M, Wolber F, Ryan US. Stimulation of rat endothelial cell transforming growth factor-β production by bleomycin. J Clin Invest 1991; 87: 148.
17. Hoyt DG, Lazo JS. Early increases in pulmonary mRNA encoding procollagens and transforming growth factor-beta in mice sensitive to cyclophosphamide-induced pulmonary fibrosis. J Pharmacol Exp Ther 1989; 249: 38.
18. Anscher MS, Crocker IR, Jirtle RL. Transforming growth factor-β1 expression in irradiated liver. Radiat Res 1990; 122: 77.
19. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477.
20. Nakatsukasa H, Nagy P, Evarts RP, Hsia C, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-β1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85: 1833.
21. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Trans-forming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139: 1221.
22. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-β. Am Rev Respir Dis 1989; 140: 95.
23. Castilla A, Prieto J, Fausto N. Transforming growth factors β and a in chronic liver disease: effects of interferon alfa therapy. N Engl J Med 1991; 324: 933.
24. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642.
25. Varga J, Haustein UF, Creech RH, Dwyer JP, Jiminez SA. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA 1991; 265: 3292.
26. Kahaleh MB, LeRoy EC. The immune basis for human fibrotic diseases, especially scleroderma (systemic sclerosis). Clin Aspects Autoimmun 1989; 3: 19.
27. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993; 328: 1592.
28. Murase T, Anscher MS, Petros WP, Peters WP, Jirtle RL. Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity. Bone Marrow Transplant 1995; 15: 173.
29. Deeg HJ, Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 1984; 35: 11.
30. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graftversus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204.
31. Ochs LA, Blazar BR, Roy J, Rest EB, Weisdorf DJ. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant 1996; 17: 1085.
32. Imamura M, Tanaka J, Hashino S, et al. Immunopathogenesis of GVHD. Transplant Proc 1996; 28: 1181.
33. Bonham CA, Lu L, Banas RA, et al. TGF-β1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed cells. Transplant Immunol 1996; 4: 186.
34. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann N Y Acad Sci 1993; 685: 713.